Concepedia

Xiwei Wang

XW

Statistics

Publications

1

Citations

12

H-Index

1

Active since

2022

Affiliations

Shandong First Medical University(Current)

Xiwei Wang is an author at Shandong First Medical University specializing in chemotherapy, synergistic inhibitor effects, and cancer cell proliferation inhibition.

ORCID

Publications per year

2022–2022

1

Publications

1

Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2‐RCHY1 mediated signaling pathway

Xiwei Wang, Yingying Zheng, Zhengbin Chai et al. · Molecular Carcinogenesis · 2022 · 12 citations

Medicine, Oncology, Pharmacology +15

1–1 of 1